News and blogs
340 results found.
Another CAR-T treatment provisionally turned down for use on NHS
The NHS medicines watchdog has provisionally recommended that a treatment called Kymriah, which uses the immune system to fight cancer, should not be made available to treat people with diffuse large B-cell lymphoma (DLBCL) who do not respond to standard treatments.
19th Sep 2018
Hugo celebrates his last day of leukaemia treatment
Hugo was diagnosed with leukaemia in 2015 at the age of two. After 3 years, 2 months and 5 days of gruelling chemotherapy, his treatment finishes today.
17th Sep 2018
Over half of Brits don’t know symptoms of blood cancer
31st Aug 2018
Blood cancer patients could be denied life-saving CAR-T therapy
28th Aug 2018
Blood cancer patients least likely to understand their diagnosis
20th Aug 2018
How myeloproliferative neoplasms disrupt the work of blood stem cells
Blood stem cells need to strike a delicate balance between making other types of blood cells and renewing themselves. When myeloproliferative neoplasms happen, this balance is disrupted. Recent research carried out by Bloodwise-funded researchers at the University of Cambridge has revealed the genetic changes that cause these disruptions.
14th Aug 2018
More people with CLL to benefit from ibrutinib in future
More people living with a type of leukaemia in England will soon have access to Ibrutinib, thanks to a successful campaign by Bloodwise and other organisations.
9th Aug 2018
I lost my partner to Diffuse large B-cell non-Hodgkin lymphoma
The story of my partner Mark and his battle with the bastard blood cancer that is Diffuse large B-cell non-Hodgkin lymphoma (DLBCL)
7th Aug 2018
Blood cancers taking longer to be diagnosed than other cancers
27th Jul 2018
Looking back on blood cancer research breakthroughs through the decades
4th Jul 2018
Successful stem cell transplants without chemotherapy or radiotherapy?
26th Jun 2018
Blood problems in newborn babies with Down's syndrome
Professor Irene Roberts explains why new guidelines are needed to identify those children with Down's syndrome at risk of developing leukaemia.
18th Jun 2018
New drug will improve survival rates for leukaemia patients in Scotland
A targeted cancer drug that reduces the chances of relapse for people with an aggressive type of leukaemia will be made available on the NHS in Scotland.
11th Jun 2018
Genetic mutation and infection 'most likely cause' of childhood leukaemia
A two-step process of a genetic mutation followed by exposure to infection is the most likely cause of the most common type of childhood leukaemia, according to a major new study by Blood Cancer UK-funded researchers
21st May 2018
People with blood cancer potentially losing access to crucial drugs
People with blood cancer risk being denied access to crucial treatments because of restrictions imposed by NHS England on the use of cancer medicines.
17th May 2018
NICE approves access to new treatments for THREE types of blood cancer
The National Institute for Health and Care Excellence (NICE) has announced today that three new types of treatment will become routinely available on the NHS for people with blood cancer in England.
4th May 2018
Bloodwise welcomes news that CAR-T cell therapy could be made available on NHS
Chimeric antigen receptor T-cell therapy (CAR-T) could be made available on the NHS this year. The pioneering treatment has shown huge promise in clinical trials around the world in people with blood cancer who fail to respond to other treatments.
26th Apr 2018
Highlights from the British Society for Haematology Annual Meeting 2018
Last week, I spent three days at the BSH Annual Meeting in Liverpool along with another member of the Bloodwise research team. Below I’ve summed up the highlights of the Meeting, including news on the Bloodwise-funded DESTINY trial and an exciting study in Cardiff where chemotherapy is being taken nearer to people’s homes.
26th Apr 2018
MP Jess Phillips meets top leukaemia scientists at Birmingham University
The Birmingham Yardley MP met Professor Paul Moss and his team at the Institute of Immunology and Immunotherapy on Friday 20 April, the day before World AML Awareness Day.
24th Apr 2018
Cambridge scientists granted over £500,000 to search for new ways to tackle AML
Two research projects are underway at the University of Cambridge that are seeking to find new ways to treat acute myeloid leukaemia (AML).
24th Apr 2018